Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Appleton, S.
Right arrow Articles by Ruffin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Appleton, S.
Right arrow Articles by Ruffin, R.
(Chest. 2003;123:1838-1846.)
© 2003 American College of Chest Physicians

Sustained Improvements in Dyspnea and Pulmonary Function 3 to 5 Years After Lung Volume Reduction Surgery*

Sarah Appleton, BSc (Hons); Robert Adams, MBBS, MD; Samuel Porter, MBBS; Morris Peacock, MBBS and Richard Ruffin, MD, FCCP

* From the Departments of Medicine (Ms. Appleton, and Drs. Adams and Ruffin) and Surgery (Mr. Peacock), University of Adelaide, The Queen Elizabeth Hospital Campus, Woodville, SA, Australia; private practice (Dr. Porter), Adelaide, SA, Australia.

Correspondence to: Robert Adams, MBBS, MD, Department of Medicine, The Queen Elizabeth Hospital, 28 Woodville Rd, Woodville, SA, Australia 5011; e-mail: robert.adams{at}nwahs.sa.gov.au

Objectives: To determine long-term survival rates of patients who underwent lung volume reduction surgery (LVRS) for emphysema and the factors associated with longer survival, and to evaluate levels of perceived dyspnea and health-related quality of life (HRQL) after a follow-up period of 3 to 5.5 years.

Design: Retrospective observational study.

Setting: Academic medical center

Methods: Telephone and postal surveys were used to obtain patient dyspnea scores and HRQL scores. Hospital databases and state registries were searched to determine patient survival and pulmonary function.

Results: Of 54 patients undergoing LVRS, 29 patients (18 men and 11 women) were available for follow-up, which ranged from 36 to 66 months (mean ± SE, 51 ± 1.5 months). There was significant sustained improvement in modified Medical Research Council scores compared to pre-LVRS: 2.19 ± 0.19 vs 2.88 ± 0.14 (p = 0.0000). Eleven of 22 patients demonstrated an increase in all three Mahler baseline dyspnea index grades of at least one level. Baseline body mass index (BMI) and post-LVRS length of stay (LOS) were significantly associated with survival: survivor vs deceased baseline BMI, 24.2 ± 0.6 vs 21.4 ± 0.5 (p = 0.002), and post-LVRS LOS, 15.4 ± 1.7 days vs 28.7 ± 5.3 days (p = 0.015). Compared to pre-LVRS, 20 patients with mean follow-up time of 45 months demonstrated significant sustained improvements in FEV1 percentage of predicted (31.4 ± 2.1% vs 39.8 ± 3.5%, p = 0.038), total lung capacity percentage of predicted (136 ± 4% vs 122 ± 3%, p = 0.0004), and residual volume percentage of predicted (237 ± 14% vs 172 ± 11%, p = 0.0001). Patient HRQL measured using the Dartmouth Primary Care Co-operative Quality of Life questionnaire was more favorable than that reported in aged-care settings. Caregiver burden scale scores indicate caring for a recipient of LVRS carries similar burden to that for caring for individuals with other chronic illnesses.

Conclusions: In this population, a majority of the LVRS patients survived for ≥ 3 years. Among survivors, dyspnea and lung function benefits were seen. Baseline BMI and postoperative LOS were significantly associated with survival.

Key Words: emphysema • lung diseases, obstructive • lung volume reduction surgery




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
Q.-Y. Tan, R.-W. Wang, Y.-G. Jiang, S.-Z. Fan, M. K.Y. Hsin, T.-Q. Gong, J.-H. Zhou, and Y.-P. Zhao
Lung Volume Reduction Surgery Allows Esophageal Tumor Resection in Selected Esophageal Carcinoma With Severe Emphysema
Ann. Thorac. Surg., November 1, 2006; 82(5): 1849 - 1856.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. B. Gorman, D. K. McKenzie, J. E. Butler, J. F. Tolman, and S. C. Gandevia
Diaphragm Length and Neural Drive after Lung Volume Reduction Surgery
Am. J. Respir. Crit. Care Med., November 15, 2005; 172(10): 1259 - 1266.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. D. Yusen and B. Littenberg
Integrating Survival and Quality of Life Data in Clinical Trials of Lung Disease: The Case of Lung Volume Reduction Surgery
Chest, April 1, 2005; 127(4): 1094 - 1096.
[Full Text] [PDF]


Home page
ChestHome page
F. Laghi, A. Jubran, A. Topeli, P. J. Fahey, E. R. Garrity Jr, D. J. de Pinto, and M. J. Tobin
Effect of Lung Volume Reduction Surgery on Diaphragmatic Neuromechanical Coupling At 2 Years
Chest, June 1, 2004; 125(6): 2188 - 2195.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Chest Physicians.